🚀 The @enginexyz’s #ToughTechSummit returns to #Boston this month! Our CEO @Nabsicle will speak on “Accelerating Tough Tech through AI & Automation” (Oct 10, 10:15 AM ET), sharing our #AI-driven vision for personalized medicines. 👉 https://t.co/uihkm2SDJf

👏 Congratulations to our Founder & CEO, @nabsicle named a 2025 @BioSpace 40 Under 40 honoree for #innovation and #patientimpact in #biotech! See the full list ➡️ https://t.co/gRtMVgwKrj

Think of your body as the greatest artwork ever created. Each cell is a brushstroke. Today our Co-Founder & CPO @MadridMarinna is launching her Substack, starting with how iPSCs let us rewind biology’s brushstrokes!🎨 Take a peek → https://t.co/sG8CDeddJL

📢 Honored to announce that our Co-Founder & CEO, @nabsicle, will be co-chairing the @NASEM_Health’s “Developing Regenerative Medicine Therapies with #AI” workshop on Nov 18 in #DC. 👉 Join us in person or online: https://t.co/qVxtJu8m3v

🧬How can #AI scale autologous iPSC therapies? Bar Makovoz, PhD, our Associate Director of Product Management, shares insights Oct 9 at @ISSCR’s AI & Digital Biology Symposium in #Seattle. Join us: https://t.co/qNf9RqhDC0

🚨 Tomorrow at The Engine in #Cambridge: Join @CellinoBio & Dr. Hideyuki Okano for breakthrough #iPSC spinal cord injury trial results + Q&A & networking. See you 12:30–2:30 PM EDT! 👉 Limited seats! Register now: https://t.co/UHz57qIckM

🗓 Join us Aug 12 at The Engine in #Cambridge for @CellinoBio's seminar with Dr. Hideyuki Okano on the world’s first clinical trial using #iPSC-derived therapy for #spinalcordinjury. Learn, ask questions, & network with #Boston’s innovation leaders! 👉 Register now:

Can't wait! Thank you for sharing, @RySciComms 🚀

📢 You’re invited! Hear Dr. Hideyuki Okano, President of @ISSCR and Professor at @Keio_Univ, share results from the world’s first #clinicaltrial using #iPSC-derived neural stem cells to treat #spinalcordinjury—where one previously paralyzed patient has even regained the ability

📢 @MadridMarinna will speak at @cira_ku_e’s Seminar Series on August 8 from 4:00 to 5:00 PM JST at Kyoto_News! She’ll present Nebula, our #AI-driven platform for scalable production of #iPSC-derived therapies. 📧 Register: research_support_g@cira.kyoto-u.ac.jp

🚀Join us in #Japan for @Keio_Univ’s 8th Regeneration & Drug Discovery Seminar on Aug 4! @MadridMarinna will speak on “Autonomous Biomanufacturing of #iPSC-Based Cell Therapies” and share our vision for a more scalable future in #healthcare. 📧 Questions or RSVP requests:

🔬 We’re honored to join leaders from across the #regenerativemedicine community at @AllianceRM’s 2025 Cell & Gene Congressional Fly-In, where @MadridMarinna, will represent @CellinoBio from July 22–23 on #CapitolHill. 🔗 https://t.co/4mtL1GakLF

📢 Excited to share @TheWillieT, our Head of Public Engagement, is a keynote speaker at @AIforGood in #Geneva on July 9! Join us for his session on #AI-driven #biomanufacturing & the future of personalized #regenmed. #AIforGood 🔗See details: https://t.co/OAaM7ddHKn

It’s been an exhilarating week in #Boston at #BIO25! We’re honored to have our Co-Founders, CEO @nabsicle and Chief Product Officer @MadridMarinna, share how we’re accelerating the development of personalized #regenmed and building toward a future of #healthequity. Thank you to

Big news! Our CEO @nabsicle has been named an Entrepreneur Of The Year 2025 New England Award Winner by @EY_US! 🎉 Her bold vision is shaping the future of regenerative medicine. Read more: https://t.co/nVdH7CHWLg #EOY25 #Cellino #RegenerativeMedicine

🚀 If you’re in #Boston next week for #BIO2025, we’re looking forward to seeing you there! Join our Co-Founders, CEO @nabsicle and Chief Product Officer @MarinnaMadrid, as they speak on early-stage #investment, advanced #biomanufacturing, and expanding #healthequity.

🧬 Join us at the ARM & Cell and Gene Therapy Catapult Workshop in #StevenageUK! @MarinnaMadrid, Co-Founder & CPO of @CellinoBio, will present on "Scaling Regenerative Medicines to Meet Global Need,” and speak on a panel discussing #AI/#ML in #biomanufacturing on June 13. 👉

We're excited to introduce Ethan Goldman as a Mechanical Engineer at @CellinoBio! After 3 years interning with us in #automation and #mechanicalengineering, his experience will support our efforts to advance #biomanufacturing for personalized medicine. Welcome aboard, Ethan! 🚀

Regulatory recognition invites reflection—not just on the science, but on the journey behind it. In this video, @MadridMarinna shares her path as a founder and regulatory leader, and what the FDA’s AMT designation means for the future of #regenmed. 🎥⬇️

Check out the latest blog from our Co-Founder & Chief Product Officer @MadridMarinna, who led the strategy that secured the @US_FDA Advanced Manufacturing Technology designation—recognizing Cellino's innovation in #regenmed manufacturing. 📖 Read it here: https://t.co/tHayKMUKQm